RAAS plays important roles in COVID‐19; therefore, the effect of RAAS inhibitors including angiotensin‐converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) in COVID‐19 is worth studying.134. This evidence concerns the gene ACE and COVID-19.